*Note: If preferred, electronic Prescriptions can be submitted through an e-prescribing software or an electronic medical record that has been certified by Surescripts. Query for Medvantx or AmeriPharm in Sioux Falls, SD 57014. NPI-1073692745 or NCPDP-4351968.
Genentech Medicines Eligible for Product Replacement
Cathflo® Activase (alteplase)
(trastuzumab and hyaluronidase-oysk)
KADCYLA® (ado-trastuzumab emtansine)
LUCENTIS® (ranibizumab injection)
PEGASYS® (peginterferon alfa-2a)
PHESGOTM (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
POLIVY™ (polatuzumab vedotin-piiq)
RITUXAN HYCELA® (rituximab/hyaluronidase human)
SusvimoTM (ranibizumab injection)
XOLAIR® (omalizumab) for subcutaneous use
HCPs can request replacement medicine when an enrolled patient was treated with medicine from their inventory via one of the following options:
Prescriptions will be distributed through our specialty pharmacy partner or through a product replacement model. For Genentech medicines that are administered by a health care provider, we are asking providers to select one distribution option. If you have questions about shipment options, a Genentech Patient Foundation Specialist can help.